NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I'm looking at all patients entering the trial being included, and I doubt if any who didn't cross over to the vaccine are in the Top 100. As I understand it, all healthy enough to cross over were permitted to, so I very much doubt that any of the roughly 30 that didn't cross over made it to 5 years or longer.

Certainly some patient groups fared better than others, but I believe the results will justify giving the vaccine to all patients with GBM.

Gary